Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!

Bed Bath & Beyond Continues To Struggle Mightily To Adapt To A New Landscape

Courtesy of Benzinga.

Bed Bath & Beyond Continues To Struggle Mightily To Adapt To A New Landscape

Bed Bath & Beyond Inc. (NASDAQ: BBBY) shares were tumbling toward an eight-year low on Friday in reaction to its fiscal year 2017 first-quarter released after the market close on Thursday.

Underwhelming Q1

Commenting on the results, Oppenheimer said the results are an ample evidence that the company continues to suffer mightily amid a shifting sector landscape. The firm noted the company reported earnings per share of $0.53, down 30 percent and below the consensus estimate of $0.66. Additionally, comps fell 2 percent, the firm said.

Analysts Brian Nagel and David Bellinger believe softer in-store sales and the ongoing margin weakness pressured results. The analysts noted that brick-and-mortar comps were down in mid-single digits, worse than the low-single-digit drop over the past several quarters, even as digital comps rose more than 20 percent.

The analysts also noted gross margins contracted 90 basis points to 36.5 percent compared to the consensus estimate of 36.8 percent.

The company maintained its 2017 earnings per share guidance for a low-single digit to a 10 percent drop, premised on flat to slightly positive comps and a lesser rate of gross margin contraction compared to a 70-basis-point contraction in 2016.

Lowering Estimates

Reflecting expectations for continued comp softness through year-end and the weak first-quarter results, Oppenheimer reduced its 2017 earnings per share estimate from $4.35 to $4.18 and its 2018 estimate from $4.30 to $4.12, with both estimates below the consensus estimates.

Oppenheimer said it remains optimistic that the company will successfully tweak its model, so as to compete more effectively in an omni-channel world. Though the pace of investment has stepped up, the firm indicated that clear signals of success are rare.

At the time of writing, shares of Bed Bath & Beyond were down 11.23 percent at $29.95.

Oppenheimer rates Bed Bath & Beyond a Perform with no specified 12–18-month price target.

Related Links:

Retail Job Losses: Does This Point Toward Protracted Sectoral Weakness

How These 3 Retailers Are Outperforming The Sector

Latest Ratings for BBBY

Date Firm Action From To
May 2017 Loop Capital Upgrades Sell Hold
Dec 2016 Raymond James Downgrades Strong Buy Market Perform
Dec 2016 Loop Capital Initiates Coverage On Sell

View More Analyst Ratings for BBBY


View the Latest Analyst Ratings

Posted-In: OppenheimerAnalyst Color Earnings News Guidance Reiteration Analyst Ratings Movers Best of Benzinga


Do you know someone who would benefit from this information? We can send your friend a strictly confidential, one-time email telling them about this information. Your privacy and your friend's privacy is your business... no spam! Click here and tell a friend!





You must be logged in to make a comment.
You can sign up for a membership or get a FREE Daily News membership or log in

Sign up today for an exclusive discount along with our 30-day GUARANTEE — Love us or leave, with your money back! Click here to become a part of our growing community and learn how to stop gambling with your investments. We will teach you to BE THE HOUSE — Not the Gambler!

Click here to see some testimonials from our members!